Category: us corporate news

us corporate news

Sensus Healthcare, Inc. 2025 Annual Report: Business Overview, Products, Market Strategy, and Regulatory Compliance

Minichart

March 5, 2026

Sensus Healthcare, Inc. 2025 Annual Report – Key Investor In...

Continue Reading 0

us corporate news

Westlake Chemical Partners 2025 Annual Report: Business Overview, Risk Factors, Financials, and Operations

Minichart

March 5, 2026

Westlake Chemical Partners LP 2025 Annual Report: Key Highli...

Continue Reading 0

us corporate news

FIRST FINANCIAL CORP /IN/ 2025 Annual 10-K Report: Financial Performance, Loan Portfolio, and Asset Details

Minichart

March 5, 2026

First Financial Corporation 2025 10-K: Key Updates for Inves...

Continue Reading 0

us corporate news

Oil States International 2025 Annual Report: Business Overview, Risk Factors, and Financial Performance

Minichart

March 5, 2026

Oil States International, Inc. 2025 Annual Report: Key Highl...

Continue Reading 0

us corporate news

United States 12 Month Natural Gas Fund, LP (UNL) 2025 Annual Report: Business, Risk Factors, Fees, Financials & SEC Filings

Minichart

March 5, 2026

United States 12 Month Natural Gas Fund, LP (UNL) 2025 Annua...

Continue Reading 0

us corporate news

Bankwell Financial Group, Inc. 2025 Annual Report Highlights: Business Strategy, Financial Performance, and Risk Management

Minichart

March 5, 2026

Bankwell Financial Group, Inc. 2025 Annual Report – Key Inve...

Continue Reading 0

us corporate news

Niagen Bioscience, Inc. (formerly ChromaDex) Company Overview, Business Segments, Products, Intellectual Property, and Market Strategy 32–56

Minichart

March 4, 2026

In-Depth Financial Review: Niagen Bioscience, Inc. 2025 Annu...

Continue Reading 0

us corporate news

SCYNEXIS, Inc. 2025 Annual Report: Business Overview, Strategy, Key Milestones & Regulatory Insights

Minichart

March 4, 2026

SCYNEXIS, Inc. 2025 Annual Report: Key Investor Highlights a...

Continue Reading 0

us corporate news

Keros Therapeutics 2025 Annual Report: Pipeline, Strategy, Regulatory Updates, and Collaborations

Minichart

March 4, 2026

Keros Therapeutics, Inc. 10-K: Key Investor Highlights ...

Continue Reading 0

us corporate news

Verastem, Inc. 2025 Annual Report: Pipeline Updates, AVMAPKI FAKZYNJA FDA Approval, and Business Overview

Minichart

March 4, 2026

Verastem, Inc. 2025 Annual Report – Investor Analysis Ve...

Continue Reading 0